The negative regulatory role of miRNAs (miR-146a and miR-31) in VCAM-1 and ICAM-1 expression causes renal inflammatory and immune response disorders and accelerates the progression of DN, indicating that miRNAs are potential therapeutic targets in the prevention/treatment of DN. The gene discussed is ICAM1; the disease is liver dysplastic nodule.